While former colleagues say Anderson is a strong pick, they worry that his impact on Bayer will be blunted near term as his laid back managerial approach he adjusts to Germany's conservative corporate culture.
While he has not decided on whether to pursue an activist-recommended breakup of Bayer, Anderson almost certainly will believe the idea has merit.
Sources were unanimously positive, citing his knowledge, leadership abilities, management-style, and ability to drive results at Genentech and its acquirer, Swiss-based Roche.
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.